Results 71 to 80 of about 11,965 (231)

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

Case Reports in Cardiology, 2022
Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang, Hui Xue, Lifu Miao, Xiujie Tang, Yanbin Shao   +4 more
doaj   +1 more source

Comparison of Latest Generation Intra‐ and Supra‐Annular Self‐Expanding Transcatheter Heart Valves for Aortic Valve‐in‐Valve Procedures

Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1873-1882, September 1, 2025.
ABSTRACT Background Valve‐in‐valve (ViV) procedures are an established therapy. Self‐expanding (SE) supra‐annular transcatheter heart valves (THV) achieve superior hemodynamics compared to balloon‐expandable (BE) intra‐annular THV, but influence of stent design versus valve position remains unclear.
Antonia Katharina Stötzel, Oliver D. Bhadra, Lara Waldschmidt, Till J. Demal, David Grundmann, Lisa Voigtländer, Stefan Blankenberg, Hermann Reichenspurner, Niklas Schofer, Andreas Schaefer   +9 more
wiley   +1 more source

Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 yearsCentral MessagePerspective

JTCVS Open
Objective: To compare early and long-term clinical outcomes of bioprosthetic versus mechanical (On-X) mitral valve replacement (MVR) in patients aged 65 years and older.
Antonio Piperata, MD, PhD, Carlo Mariani, MD, PhD, Giacomo Murana, MD, PhD, Elio Fabbri, PhD, Paola Rucci, PhD, Maria Francesca Scuppa, MD, Filippo Londi, MD, Edoardo Bianco, MD, Benedetta Guerrini, MD, Ivan Tammaro, MD, Ludovica Fabiani, MD, Margherita Careddu, MD, Marta Bellomare, MD, Silvia Snaidero, MD, Riccardo Nania, MD, Sabrina Castagnini, MD, Marta Di Carlo, MD, Valentina Orioli, MD, Gianluca Folesani, MD, Davide Pacini, MD, PhD   +19 more
doaj   +1 more source

Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States

Mycoses, Volume 68, Issue 9, September 2025.
ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, Alessandro Limongelli, Antonio Vena, Julia Götz, Stilla Bauernfeind, Frank Hanses, Lukas Tometten, Michael Mayer, Ansgar Rieke, Ana Soriano‐Martin, Maricela Valerio, Jose A. Vazquez, Patrick Yue, Laman Rahimli, Nijat Azimli, Ertan Sal, Jon Salmanton‐García, Natalia Vasenda, Rosanne Sprute, Jannik Stemler, Sebastian Wingen‐Heimann, Oliver A. Cornely, Danila Seidel   +24 more
wiley   +1 more source

Chronic kidney disease and valvular heart disease: State of the art

Physiological Reports, Volume 13, Issue 18, September 2025.
Abstract Chronic kidney disease (CKD) and valvular heart disease (VHD) frequently coexist and are associated with a significant increase in morbidity and mortality. Their interplay is complex and multifactorial, involving shared pathophysiological mechanisms such as chronic inflammation, mineral and bone disorder, vascular and valvular calcification ...
S. Saltarocchi, M. D'Abramo, P. De Orchi, F. Spunticchia, M. Totaro, E. M. Cirio, F. Miraldi   +6 more
wiley   +1 more source

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 992-1001, August 1, 2025.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source

Isolated aortic valve replacement with the Björk-Shiley tilting disc prosthesis and the porcine bioprosthesis [PDF]

, 2017
Between 1977 and 1978, 239 patients underwent aortic valve replacement with either a bioprosthesis (100, BIO) or a Björk-Shiley tilling disc prosthesis (139, BS). Early mortality was 2%, late mortality 4%.
EGLOFF, L., ROTHLIN, M., SENNING, Å., TURINA, M.   +3 more
core  

Sutureless bioprosthesis thrombosis

Acta Cardiologica, 2022
Deneye, Manon, Marchetta, Stella, Dulgheru, Raluca, Szecel, Delphine, Radermecker, Marc, Lancellotti, Patrizio   +5 more
openaire   +3 more sources

Trifecta Bioprosthesis Midterm Results [PDF]

The Annals of Thoracic Surgery, 2020
Hassan, Kattach, Sunil Kumar, Ohri
openaire   +2 more sources

Bioprosthetic Valve Fracturing in Valve‐in‐Valve TAVI: Clinical and Echocardiographic Outcomes in Failing Perimount Aortic Bioprostheses—A Multicenter Registry

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1409-1420, August 1, 2025.
ABSTRACT Background Data comparing clinical and hemodynamic outcomes of bioprosthetic valve fracturing (BVF) and “standard”‐postdilatation during valve‐in‐valve transcatheter heart valve implantation (ViV‐TAVI) are lacking. The authors aimed to analyze hemodynamic and clinical outcomes of BVF compared to “standard”‐postdilatation during ViV‐TAVI ...
Hendrik Ruge, Melchior Burri, Julia Schreyer, Teodora‐Cristiana Georgescu, Derk Frank, Won‐Keun Kim, Ole de Backer, Martin Beyer, Andreas Schäfer, Chiara Fraccaro, Giuseppe Tarantini, Erion Xhepa, Michael Joner, Markus Krane, Héctor Alfonso Alvarez Covarrubias   +14 more
wiley   +1 more source